Efficacy and safety of linagliptin in T2D with poor glycemic control

Linagliptin was an effective, well-tolerated treatment in subjects with T2DM and insufficient glycemic control, both as monotherapy or added-on to metformin/metformin plus sulfonylurea (Journal of Diabetes and Its Complications)